BioSpace News Archive

CSL Seqirus, a part of CSL Limited (ASX:CSL), today announced new data will be presented at the Options for the Control of Influenza (OPTIONS XI) conference taking place September 26-29, 2022 in Belfast, United Kingdom.

Aerie Pharmaceuticals to Host Key Opinion Leader Event on Dry Eye Disease: Current Landscape, Unmet Needs, and Emerging Treatment Options.

WCG, the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced the expansion of its Phase I review services, providing purpose-built operations for Phase I investigators.

The Sanger Sequencing Services Market is expected to grow at a CAGR of 6.5% during the forecast period , according to latest analysis by Emergen Research.

Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) announced today initiation of a series of phased experiments to begin the process of moving its CAR-T cell de-differentiation approach through pre-clinical validation.

The latest market analysis report published by Reports and Data, titled ‘Global Peripheral Neuritis Treatment Market – Forecast to 2030,’ thoroughly examines the Peripheral Neuritis Treatment industry to provide essential data & information for the targeted readers.

Zealand Pharma A/S announces granting of warrants to employees in accordance with Zealand’s Remuneration policy and overall guidelines for incentive pay, as adopted at the annual general meeting held on April 6, 2022.

Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma or the Company), a global, clinical-stage biopharmaceutical company developing T cell-driven therapies to treat inflammatory diseases, today announced financial results for the six-month period ended June 30 and recent corporate highlights.

McKesson Corporation announced that LeAnn B. Smith has been selected to become executive vice president and chief human resources officer.